Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example-Reference-Cited by-同舟云学术

Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example

Published:2020-02 Issue:2 Volume:23 Page:217-226
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Dong Yaa-Hui,Wang Shirley V.,Gagne Joshua J.,Wu Li-Chiu,Chang Chia-Hsuin

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference28 articles.

1. The case-crossover design: a method for studying transient effects on the risk of acute events;Maclure;Am J Epidemiol,1991

2. The case-time-control design;Suissa;Epidemiology,1995

3. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research;Schneeweiss;Pharmacoepidemiol Drug Saf,1997

4. The case-crossover study design in pharmacoepidemiology;Delaney;Stat Methods Med Res,2009

5. Use of self-controlled designs in pharmacoepidemiology;Hallas;J Intern Med,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug–Drug–Drug Interactions Among High‐Risk Populations;Clinical Pharmacology & Therapeutics;2024-06-11

2. Benzodiazepine Use During Pregnancy and Risk of Miscarriage;JAMA Psychiatry;2023-12-27

3. Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review;Pharmacoepidemiology and Drug Safety;2023-06-15

4. Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-01-19

5. Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies;Frontiers in Cardiovascular Medicine;2022-09-23